APO RESEARCH · REPORT
POC Diagnostics
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Product & engineering
Understand the product.
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Selected research
Industry Research
POC Diagnostics Industry Research Report 2026
Market perspective
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%.
In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc.
Read the full market overview
Report Scope
This report quantifies the global POC Diagnostics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
POC Diagnostics Market by Company
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
POC Diagnostics Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas or Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
POC Diagnostics Segment by Application
Clinics
Hospitals
Laboratory
Others
POC Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global POC Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of POC Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of POC Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of POC Diagnostics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of POC Diagnostics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of POC Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas or Electrolytes Testing
- Tumor Markers Testing
- Urinalysis Testing
- Cholesterol Testing
- Others
Applications
- Clinics
- Hospitals
- Laboratory
- Others
Companies covered
- Alere
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Bayer Healthcare
- Beckman Coulter
- Nipro Diagnostics
- Bio-Rad Laboratories
- Nova Biomedical
- BioMerieux
- Quidel
- Helena Laboratories
- OraSure Technologies
- Accriva
- Abaxis
- Chembio Diagnostics
- Trinity Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global POC Diagnostics Market Size (2021-2032)
- 2.2.2 Global POC Diagnostics Sales (2021-2032)
- 2.2.3 Global POC Diagnostics Market Average Price (2021-2032)
- 2.3 POC Diagnostics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Blood Glucose Testing
- 2.3.3 Infectious Diseases Testing
- 2.3.4 Cardiac Markers Testing
- 2.3.5 Coagulation Testing
- 2.3.6 Pregnancy and Fertility Testing
- 2.3.7 Blood Gas or Electrolytes Testing
- 2.3.8 Tumor Markers Testing
- 2.3.9 Urinalysis Testing
- 2.3.10 Cholesterol Testing
- 2.3.11 Others
- 2.4 POC Diagnostics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
- 2.4.4 Laboratory
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global POC Diagnostics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global POC Diagnostics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global POC Diagnostics Revenue of Manufacturers (2021-2026)
- 3.4 Global POC Diagnostics Average Price by Manufacturers (2021-2026)
- 3.5 Global POC Diagnostics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of POC Diagnostics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of POC Diagnostics, Product Type & Application
- 3.8 Global Manufacturers of POC Diagnostics, Established Date
- 3.9 Global POC Diagnostics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alere
- 4.1.1 Alere Company Information
- 4.1.2 Alere Business Overview
- 4.1.3 Alere POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alere POC Diagnostics Product Portfolio
- 4.1.5 Alere Recent Developments
- 4.2 Roche
- 4.2.1 Roche Company Information
- 4.2.2 Roche Business Overview
- 4.2.3 Roche POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roche POC Diagnostics Product Portfolio
- 4.2.5 Roche Recent Developments
- 4.3 Abbott Laboratories
- 4.3.1 Abbott Laboratories Company Information
- 4.3.2 Abbott Laboratories Business Overview
- 4.3.3 Abbott Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abbott Laboratories POC Diagnostics Product Portfolio
- 4.3.5 Abbott Laboratories Recent Developments
- 4.4 Johnson & Johnson
- 4.4.1 Johnson & Johnson Company Information
- 4.4.2 Johnson & Johnson Business Overview
- 4.4.3 Johnson & Johnson POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Johnson & Johnson POC Diagnostics Product Portfolio
- 4.4.5 Johnson & Johnson Recent Developments
- 4.5 Siemens Healthcare
- 4.5.1 Siemens Healthcare Company Information
- 4.5.2 Siemens Healthcare Business Overview
- 4.5.3 Siemens Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Siemens Healthcare POC Diagnostics Product Portfolio
- 4.5.5 Siemens Healthcare Recent Developments
- 4.6 Danaher
- 4.6.1 Danaher Company Information
- 4.6.2 Danaher Business Overview
- 4.6.3 Danaher POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Danaher POC Diagnostics Product Portfolio
- 4.6.5 Danaher Recent Developments
- 4.7 Bayer Healthcare
- 4.7.1 Bayer Healthcare Company Information
- 4.7.2 Bayer Healthcare Business Overview
- 4.7.3 Bayer Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Healthcare POC Diagnostics Product Portfolio
- 4.7.5 Bayer Healthcare Recent Developments
- 4.8 Beckman Coulter
- 4.8.1 Beckman Coulter Company Information
- 4.8.2 Beckman Coulter Business Overview
- 4.8.3 Beckman Coulter POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Beckman Coulter POC Diagnostics Product Portfolio
- 4.8.5 Beckman Coulter Recent Developments
- 4.9 Nipro Diagnostics
- 4.9.1 Nipro Diagnostics Company Information
- 4.9.2 Nipro Diagnostics Business Overview
- 4.9.3 Nipro Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Nipro Diagnostics POC Diagnostics Product Portfolio
- 4.9.5 Nipro Diagnostics Recent Developments
- 4.10 Bio-Rad Laboratories
- 4.10.1 Bio-Rad Laboratories Company Information
- 4.10.2 Bio-Rad Laboratories Business Overview
- 4.10.3 Bio-Rad Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bio-Rad Laboratories POC Diagnostics Product Portfolio
- 4.10.5 Bio-Rad Laboratories Recent Developments
- 4.11 Nova Biomedical
- 4.11.1 Nova Biomedical Company Information
- 4.11.2 Nova Biomedical Business Overview
- 4.11.3 Nova Biomedical POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nova Biomedical POC Diagnostics Product Portfolio
- 4.11.5 Nova Biomedical Recent Developments
- 4.12 BioMerieux
- 4.12.1 BioMerieux Company Information
- 4.12.2 BioMerieux Business Overview
- 4.12.3 BioMerieux POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BioMerieux POC Diagnostics Product Portfolio
- 4.12.5 BioMerieux Recent Developments
- 4.13 Quidel
- 4.13.1 Quidel Company Information
- 4.13.2 Quidel Business Overview
- 4.13.3 Quidel POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Quidel POC Diagnostics Product Portfolio
- 4.13.5 Quidel Recent Developments
- 4.14 Helena Laboratories
- 4.14.1 Helena Laboratories Company Information
- 4.14.2 Helena Laboratories Business Overview
- 4.14.3 Helena Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Helena Laboratories POC Diagnostics Product Portfolio
- 4.14.5 Helena Laboratories Recent Developments
- 4.15 OraSure Technologies
- 4.15.1 OraSure Technologies Company Information
- 4.15.2 OraSure Technologies Business Overview
- 4.15.3 OraSure Technologies POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 OraSure Technologies POC Diagnostics Product Portfolio
- 4.15.5 OraSure Technologies Recent Developments
- 4.16 Accriva
- 4.16.1 Accriva Company Information
- 4.16.2 Accriva Business Overview
- 4.16.3 Accriva POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Accriva POC Diagnostics Product Portfolio
- 4.16.5 Accriva Recent Developments
- 4.17 Abaxis
- 4.17.1 Abaxis Company Information
- 4.17.2 Abaxis Business Overview
- 4.17.3 Abaxis POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Abaxis POC Diagnostics Product Portfolio
- 4.17.5 Abaxis Recent Developments
- 4.18 Chembio Diagnostics
- 4.18.1 Chembio Diagnostics Company Information
- 4.18.2 Chembio Diagnostics Business Overview
- 4.18.3 Chembio Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Chembio Diagnostics POC Diagnostics Product Portfolio
- 4.18.5 Chembio Diagnostics Recent Developments
- 4.19 Trinity Biotech
- 4.19.1 Trinity Biotech Company Information
- 4.19.2 Trinity Biotech Business Overview
- 4.19.3 Trinity Biotech POC Diagnostics Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Trinity Biotech POC Diagnostics Product Portfolio
- 4.19.5 Trinity Biotech Recent Developments
5 Global POC Diagnostics Market Scenario by Region
- 5.1 Global POC Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global POC Diagnostics Sales by Region: 2021-2032
- 5.2.1 Global POC Diagnostics Sales by Region: 2021-2026
- 5.2.2 Global POC Diagnostics Sales by Region: 2027-2032
- 5.3 Global POC Diagnostics Revenue by Region: 2021-2032
- 5.3.1 Global POC Diagnostics Revenue by Region: 2021-2026
- 5.3.2 Global POC Diagnostics Revenue by Region: 2027-2032
- 5.4 North America POC Diagnostics Market Facts & Figures by Country
- 5.4.1 North America POC Diagnostics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America POC Diagnostics Sales by Country (2021-2032)
- 5.4.3 North America POC Diagnostics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe POC Diagnostics Market Facts & Figures by Country
- 5.5.1 Europe POC Diagnostics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe POC Diagnostics Sales by Country (2021-2032)
- 5.5.3 Europe POC Diagnostics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific POC Diagnostics Market Facts & Figures by Country
- 5.6.1 Asia Pacific POC Diagnostics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific POC Diagnostics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific POC Diagnostics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America POC Diagnostics Market Facts & Figures by Country
- 5.7.1 South America POC Diagnostics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America POC Diagnostics Sales by Country (2021-2032)
- 5.7.3 South America POC Diagnostics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa POC Diagnostics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa POC Diagnostics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa POC Diagnostics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa POC Diagnostics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global POC Diagnostics Sales by Type (2021-2032)
- 6.1.1 Global POC Diagnostics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global POC Diagnostics Sales Market Share by Type (2021-2032)
- 6.2 Global POC Diagnostics Revenue by Type (2021-2032)
- 6.2.1 Global POC Diagnostics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global POC Diagnostics Revenue Market Share by Type (2021-2032)
- 6.3 Global POC Diagnostics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global POC Diagnostics Sales by Application (2021-2032)
- 7.1.1 Global POC Diagnostics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global POC Diagnostics Sales Market Share by Application (2021-2032)
- 7.2 Global POC Diagnostics Revenue by Application (2021-2032)
- 7.2.1 Global POC Diagnostics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global POC Diagnostics Revenue Market Share by Application (2021-2032)
- 7.3 Global POC Diagnostics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 POC Diagnostics Value Chain Analysis
- 8.1.1 POC Diagnostics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 POC Diagnostics Production Mode & Process
- 8.2 POC Diagnostics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 POC Diagnostics Distributors
- 8.2.3 POC Diagnostics Customers
9 Global POC Diagnostics Analyzing Market Dynamics
- 9.1 POC Diagnostics Industry Trends
- 9.2 POC Diagnostics Industry Drivers
- 9.3 POC Diagnostics Industry Opportunities and Challenges
- 9.4 POC Diagnostics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst